Prostate cancer incidence varies among males from different Y-chromosome lineages

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 3, 2006, Pages 303-309

  Ewis, Ashraf A ^a,e   Lee, J ^b   Naroda, T ^b   Sano, T ^b   Kagawa, S ^b   Iwamoto, T ^c   Shinka, T ^b   Shinohara, Y ^d   Ishikawa, M ^a   Baba, Y ^a,f   Nakahori, Y ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e Minia University   (Egypt)

^f NAGOYA UNIVERSITY   (Japan)

Author keywords

Haplogroups; Japanese; Prostate cancer; Susceptibility; Y chromosome lineages

Indexed keywords

ARTICLE; ASIA; CANCER GRADING; CANCER INCIDENCE; CANCER RESISTANCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNOLOGY; GENETIC VARIABILITY; GEOGRAPHY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOM SAMPLE; RELIABILITY; RISK ASSESSMENT; SRY GENE; Y CHROMOSOME;

CARCINOMA; CHROMOSOMES, HUMAN, Y; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; JAPAN; MALE; PHENOTYPE; PROSTATIC NEOPLASMS;

EID: 33748262450     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500876     Document Type: Article

References (59)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
3. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
4. Taylor JD, Holmes TM, Swanson GM. Descriptive epidemiology of prostate cancer in metropolitan Detroit. Cancer (1994; 73: 1704-1707.
5. Oishi K, Yoshida O, Schroeder FH. The geography of prostate cancer and its treatment in Japan. Cancer Surv 1995; 23: 267-280.
6. Sata F, Umemura T, Kishi R. The epidemiology of prostate cancer - recent trends in prostate cancer incidence and mortality. Gan To Kagaku Ryoho 2001; 28: 184-188.
7. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-3371.
8. Gronberg H. Prostate cancer epidemiology. Lancet 2003; 361: 859-864.
9. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 1992; 4: 16-24.
10. Konig JJ, Teubel W, van Dongen JW, Romijin JC, Hagemeijer A, Schroder FH. Loss and gain of chromosomes 1, 18, and Y in prostate cancer. Prostate 1994; 25: 281-291.
11. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994; 54: 3998-4002.
12. Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL. Chromosomal clues to the development of prostate tumors. Prostate 1999; 38: 303-312.
13. Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Rosenberg C et al. Identification of genetic markers for prostatic cancer progression. Lab Invest 2000; 80: 931-942.
14. Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H et al. A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J Biomed Sci 2003; 10: 430-435.
15. Van Dekken H, Alers J. Loss of chromosome Y in prostatic cancer cells but not in stromal tissue. Cancer Genet Cytogenet 1993; 66: 131-132.
16. Alers JC, Krijtenburg PJ, Vissers CJ, Bosman FT, van der Kwast TH, Van Dekken H. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer. Cytometry 1995; 21: 84-94.
17. Lau YF, Zhang J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol Carcinog 2000; 27: 308-321.
18. Kasahara K, Taguchi T, Yamasaki I, Karashima T, Kamada M, Yuri K et al. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy. Int J Oncol 2001; 19: 543-549.
19. Karan D, Schmied BM, Dave BJ, Wittel UA, Lin MF, Batra SK. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations. Clin Cancer Res 2001; 7: 3472-3480.
20. Dasari VK, Deng D, Perinchery G, Yeh CC, Dahiya R. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer. J Urol 2002; 167: 335-338.
21. Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R. Deletion of Y-chromosome specific genes in human prostate cancer. J Urol 2000; 163: 1339-1342.
22. Dasari VK, Goharderakhshan RZ, Perinchery G, Li LC, Tanaka Y, Alonzo J et al. Expression analysis of Y chromosome genes in human prostate cancer. J Urol 2001; 165: 1335-1341.
23. Jordan JJ, Hanlon AL, Al-Saleem TI, Greenberg RE, Tricoli JV. Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genet Cytogenet 2001; 124: 122-126.
24. Jobling M, Tyler-Smith C. Father and sons - the Y chromosome and human evolution. Trends Genet 1995; 11: 449-456.
25. Jobling MA, Tyler-Smith C. New uses for new haplotypes the human Y chromosome, disease and selection. Trends Genet 2000; 16: 356-362.
26. Shinka T, Tomita K, Toda T, Kotliarova SE, Lee J, Kuroki Y et al. Genetic variations on the Y chromosome in the Japanese population and implications for modern human Y chromosome lineage. J Hum Genet 1999; 44: 240-245.
27. Kuroki Y, Iwamoto T, Lee JW, Yoshike M, Nozawa S, Nishida T et al. Spermatogenic ability is different among males in different Y chromosome lineage. J Hum Genet 1999; 44: 289-292.
28. Y Chromosome Consortium. A nomenclature system for the tree of human Y-chromosomal binary haplogroups. Genome Res 2002; 12: 339-348.
29. The Japanese Urological Association and the Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Prostate Cancer, 2nd edn, Kanahara-Shuppan Co.: Tokyo, Japan, 1992.
30. Gleason DF, the VACURG. Histological grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed). Urologic Pathology. Lea & Febiger: Philadelphia, 1977, pp 171-197.
31. International Union Against Cancer. Urological tumours: Prostate. In: Hermanek P, Sobin LH (eds). TNM Classification of Malignant Tumors, 4th edn, Springer-Verlag: Berlin, 1992, pp 141-144.
32. Sambrook F, Fritsch EF, Maniathis T. Molecular Cloning: A Laboratoty Manual, 2nd edn, Cold Spring Harbor Laboratory Press: New York, 1989.
33. Hammer MF. A recent insertion of an Alu element on the Y chromosome is a useful marker for human population studies. Mol Biol Evol 1994; 11: 749-761.
34. Hammer MF, Horai S. Y chromosomal DNA variation and the peopling of Japan. Am J Hum Genet 1995; 56: 951-962.
35. Nakahori Y. A hypothesis on the evolution of sex chromosomes. Front Endocrinol 1996; 17: 1-14.
36. De-Rosa M, De-Brasi D, Zarrilli S, Paesano L, Pivonello R, D'Agostino A et al. Short stature and azoospermia in a patient with Y chromosome long arm deletion. J Endocrinol Invest 1997; 20: 623-628.
37. Vogt PH. Human Y chromosome deletions in Yq11 and male fertility. Adv Exp Med Biol 1997; 424: 17-30.
38. Bourgeron T, Barbaux S, McElreavey K, Fellous M. Y chromosome and spermatogenesis. Contracept Fertil Sex 1997; 25: 620-625.
39. Salo P, Ignatius J, Simola KO, Tahvanainen E, Kaariainen H. Clinical features of nine males with molecularly defined deletions of the Y chromosome long arm. J Med Genet 1995; 32: 711-715.
40. Maxson SC. Searching for candidate genes with effects on an agonistic behavior, offense, in mice. Behav Genet 1996; 26: 471-476.
41. Corballis MC, Lee K, McManus IC, Crow TJ. Location of the handedness gene on the X and Y chromosomes. Am J Med Genet 1996; 67: 50-52.
42. Alvesalo L. Sex chromosomes and human growth. A dental approach. Hum Genet 1997; 101: 1-5.
43. Crow TJ. Commentary on Annett, Yeo et al., Klar, Saugstad and Orr: cerebral asymmetry, language and psychosis-the case for a Homo sapiens-specific sex-linked gene for brain growth. Schizophr Res 1999; 39: 219-231.
44. Kittles RA, Bergen AW, Urbanek M, Virkkunen M, Linnoila M, Goldman D et al. Autosomal, mitochondrial, and Y chromosome DNA variation in Finland: evidence for a male-specific bottle-neck. Am J Phys Anthropol 1999; 108: 381-399.
45. Ellis JA, Stebbing M, Harrap SB. Association of the human Y chromosome with high blood pressure in the general population. Hypertension 2000; 36: 731-733.
46. Krausz C, Quintana-Murci L, Rajpert-De Meyts E, Jorgensen N, Jobling MA, Rosser ZH et al. Identification of a Y chromosome haplogroup associated with reduced sperm counts. Hum Mol Genet 2001; 10: 1873-1877.
47. Ellis JA, Stebbing M, Harrap SB. Significant population variation in adult male height associated with the Y chromosome and the aromatase gene. J Clin Endocrinol Metab 2001; 86: 4147-4150.
48. Ewis AA, Lee J, Naroda T, Sasahara K, Sano T, Kagawa S et al. Linkage between prostate cancer incidence and different alleles of the human Y-linked tetranucleotide polymorphism DYS19. J Med Invest 2002; 49: 56-60.
49. Quintana-Murci L, Weale ME, Thomas MG, Erdei E, Bradman N, Shanks JH et al. Y chromosome haplotypes and testicular cancer in the English population. J Med Genet 2003; 40: E20.
50. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR et al. Family history and prostate cancer risk in black, white, and Asian men in the united states and Canada. Am J Epidemiol 1995; 141: 732-740.
51. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: Molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 1995; 57: 1400-1407.
52. Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet 1999; 64: 921-927.
53. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 1996; 5: 1801-1807.
54. Oakey R, Tyler-Smith C. Y chromosome DNA haplotyping suggests that most European and Asian men are descended from one of two males. Genomics 1990; 7: 325-330.
55. Catalona WJ. Management of cancer of the prostate. N Engl J Med 1994; 331: 996-1004.
56. Suzuki H, Ueda T, Ichikawa T, Ito H. Androgen receptor involvement in the progression of prostate cancer. Endocr Relat Cancer 2003; 10: 209-216.
57. Yuan X, Lu ML, Li T, Balk SP. SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem 2001; 276: 46647-46654.
58. Hemminki K, Dong C, Vaittinen P. Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 2001; 20: 247-257.
59. Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med 2002; 113 (Suppl 9B): 63S-70S.